top of page
Perceived need for treatment is associated with patient satisfaction after a switch to a biosimilar; health literacy is often limited: a prospective multicentre observational study of 232 patients
L. Gossec, G. Bouguen, H. Marotte, L. Foulley, C. Habauzit, S. Benkhalifa, V. Abitbol. EULAR 2024. 12-15 June 2024, Vienna, Austria....
14 juin 2024
Patient satisfaction and experience after a switch to an adalimumab biosimilar with high concentration and citrate-free: results from a multicentric prospective real-life study
H. Marotte, L. Gossec, V. Abitbol, E. Senbel, G. Bonnaud, X. Roblin, Y. Bouhnik, S. Nancey, N. Mathieu, J. Filippi, L. Vuitton, S. Nahon,...
9 juin 2024
Patient satisfaction and experience after a switch to an adalimumab biosimilar with high concentration and citrate-free: results from a multicentric prospe
Bouguen G, Gossec L, Abitbol V, et al. Poster - P884. 19th Congress of ECCO Stockholm, Sweden, February 21-24, 2024 Background: Switching...
29 févr. 2024
Celltrion | YU-MATTER | MICI & RIC | e-cohorte
L’étude YU-MATTER est une e-cohorte centrée patient qui a pour but d’évaluer la satisfaction globale des patients relative à l'injection...
25 sept. 2023
![How to assess the satisfaction of patients with chronic inflammatory diseases after switching [...]](https://static.wixstatic.com/media/nsplsh_524776786d6f7552696f45~mv2.jpg/v1/fill/w_1333,h_1000,fp_0.50_0.50,q_30,blur_30,enc_avif,quality_auto/nsplsh_524776786d6f7552696f45~mv2.jpg)
![How to assess the satisfaction of patients with chronic inflammatory diseases after switching [...]](https://static.wixstatic.com/media/nsplsh_524776786d6f7552696f45~mv2.jpg/v1/fill/w_1072,h_804,fp_0.50_0.50,q_90,enc_avif,quality_auto/nsplsh_524776786d6f7552696f45~mv2.jpg)
How to assess the satisfaction of patients with chronic inflammatory diseases after switching [...]
Bouguen G, Peyrin-Biroulet L, Buisson A, Lafarge D, Tropé S, Montagu G, et al., Congrès EULAR 2023, AB1826-HPR (Mai 2023) Background :...
29 mars 2023
![Comment évaluer la satisfaction des patients atteints de maladies inflammatoires chroniques [...]](https://static.wixstatic.com/media/nsplsh_cc76f3360da94af794acda9a47a99070~mv2.jpg/v1/fill/w_1333,h_1000,fp_0.50_0.50,q_30,blur_30,enc_avif,quality_auto/nsplsh_cc76f3360da94af794acda9a47a99070~mv2.jpg)
![Comment évaluer la satisfaction des patients atteints de maladies inflammatoires chroniques [...]](https://static.wixstatic.com/media/nsplsh_cc76f3360da94af794acda9a47a99070~mv2.jpg/v1/fill/w_1072,h_804,fp_0.50_0.50,q_90,enc_avif,quality_auto/nsplsh_cc76f3360da94af794acda9a47a99070~mv2.jpg)
Comment évaluer la satisfaction des patients atteints de maladies inflammatoires chroniques [...]
Bouguen G, Peyrin-Biroulet L, Buisson A, Lafarge D, Tropé S, Montagu G, et al., Congrès JFHOD 2023 P.530 Introduction : L’adhésion des...
23 mars 2023
bottom of page